CIK 0001671858
- Non-accelerated filer
- Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811489190
- Phone
- +1 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-08 | Tanimoto Sarina Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +82,733 | 82,733 | ||
| 2022-11-08 | Tanimoto Sarina Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +236,380 | 236,380 | ||
| 2022-11-08 | Tanimoto Sarina Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +236,380 | 236,380 | ||
| 2022-11-08 | Lowenthal Richard E President and CEO | Grant or award | +5,176,822 | 5,176,822 | ||
| 2022-11-08 | Lowenthal Richard E President and CEO | Grant or award | +1,772,850 | 1,772,850 | ||
| 2022-11-08 | Lowenthal Richard E President and CEO | Grant or award | +4,326,854 | 4,326,854 | ||
| 2022-11-08 | Lowenthal Richard E President and CEO | Grant or award | +1,772,850 | 1,772,850 | ||
| 2022-11-08 | Lowenthal Richard E President and CEO | Grant or award · Employee Stock Option (right to buy) | +236,380 | 236,380 | ||
| 2022-11-08 | Lowenthal Richard E President and CEO | Grant or award · Employee Stock Option (right to buy) | +236,380 | 236,380 | ||
| 2022-11-08 | Lowenthal Richard E President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +82,733 | 82,733 | ||
| 2022-11-08 | Lowenthal Richard E President and CEO | Grant or award · Employee Stock Option (right to buy) | +82,733 | 82,733 | ||
| 2022-11-08 | SAUNDERS BRENT L Director | Grant or award · Stock option (right to buy) | +590,950 | 590,950 | ||
| 2022-11-08 | SAUNDERS BRENT L Director | Grant or award · Stock option (right to buy) | +153,647 | 153,647 | ||
| 2022-11-08 | Kelly Michael Director | Grant or award | +83,225 | 83,225 | ||
| 2022-11-08 | Kelly Michael Director | Grant or award · Employee Stock Option (right to buy) | +70,422 | 70,422 | ||
| 2022-11-08 | Kelly Michael Director | Grant or award · Employee Stock Option (Right to Buy) | +118,190 | 118,190 | ||
| 2022-11-08 | Dadoo Rajeev Director | Grant or award | +3,009,677 | 3,009,677 | ||
| 2022-11-08 | Scott Kathleen D. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +827,330 | 827,330 | ||
| 2022-11-08 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +2,106,774 | 2,106,774 | ||
| 2022-11-08 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +902,904 | 902,904 |
Page 25 of 31 · 602 trades